Logo.png
Advanced Melanoma Clinical Trial Pipeline Analysis Demonstrates 55+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight
July 08, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, July 08, 2024 (GLOBE NEWSWIRE) -- Advanced Melanoma Clinical Trial Pipeline Analysis Demonstrates 55+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm,...
Logo.png
Thyroid Eye Disease Market to Accelerate Substantially by 2034, Assesses DelveInsight | Key Companies Developing Therapies - Viridian Therapeutics, Roche, Immunovant, Amgen, Sling Therapeutics, ACELYRIN, Tourmaline Bio
July 04, 2024 16:00 ET | DelveInsight Business Research LLP
New York, USA, July 04, 2024 (GLOBE NEWSWIRE) -- Thyroid Eye Disease Market to Accelerate Substantially by 2034, Assesses DelveInsight | Key Companies Developing Therapies - Viridian Therapeutics,...
Logo.png
EGFR Non-Small Cell Lung Cancer Clinical Trial Pipeline Appears Robust With 37+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
July 03, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, July 03, 2024 (GLOBE NEWSWIRE) -- EGFR Non-Small Cell Lung Cancer Clinical Trial Pipeline Appears Robust With 37+ Key Pharma Companies Actively Working in the Therapeutics Segment |...
Logo.png
Atopic Dermatitis Market to Register Incremental Growth by 2034, Examines DelveInsight | Key Companies - Arcutis Biotherapeutics, Amgen, Kyowa Kirin, Dermavant Sciences, Cara Therapeutics, Pfizer, Arena Pharmaceuticals
July 02, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, July 02, 2024 (GLOBE NEWSWIRE) -- Atopic Dermatitis Market to Register Incremental Growth by 2034, Examines DelveInsight | Key Companies - Arcutis Biotherapeutics, Amgen, Kyowa Kirin,...
Logo.png
Advanced Kidney Cancer Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 50+ Companies Working in the Domain
July 01, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, July 01, 2024 (GLOBE NEWSWIRE) -- Advanced Kidney Cancer Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 50+ Companies Working in...
Logo.png
S1PR Modulators Market to Register Immense Growth During the Study Period (2020–2034) | DelveInsight
June 27, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, June 27, 2024 (GLOBE NEWSWIRE) -- S1PR Modulators Market to Register Immense Growth During the Study Period (2020–2034) | DelveInsight  The S1PR modulators market is expected to...
Logo.png
GLP-1 Agonists Market to Grow Rapidly by 2034, Predicts DelveInsight | Key Companies - Novo Nordisk A/S, Veru Inc., Viking Therapeutics, Inc., Terns Pharmaceuticals, Inc., Eccogene, AstraZeneca
June 26, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, June 26, 2024 (GLOBE NEWSWIRE) -- GLP-1 Agonists Market to Grow Rapidly by 2034, Predicts DelveInsight | Key Companies - Novo Nordisk A/S, Veru Inc., Viking Therapeutics, Inc., Terns...
Logo.png
PDE4 Inhibitor Market to Exhibit Substantial Growth Rate During the Study Period (2020–2034) | DelveInsight
June 25, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, June 25, 2024 (GLOBE NEWSWIRE) -- PDE4 Inhibitor Market to Exhibit Substantial Growth Rate During the Study Period (2020–2034) | DelveInsight  The PDE4 inhibitor market is poised for...
Logo.png
Global Cardiac Restoration Systems Market is Projected to Grow at a CAGR of ~5% by 2030| DelveInsight
May 20, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, May 20, 2024 (GLOBE NEWSWIRE) -- Global Cardiac Restoration Systems Market is Projected to Grow at a CAGR of ~5% by 2030| DelveInsight  The cardiac restoration systems market is...
Logo.png
Motor Neuron Disease Clinical Trial Pipeline Appears Robust With 120+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
May 16, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, May 16, 2024 (GLOBE NEWSWIRE) -- Motor Neuron Disease Clinical Trial Pipeline Appears Robust With 120+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight...